In this episode, Elisabeth Binder, Germany, explores how stress leaves lasting biological marks through genetic and epigenetic mechanisms. In conversation with Jelena Brasanac, Germany, she discusses how discoveries in stress-related genes and pathways, such as FKBP5, have paved the way toward a deeper understanding of vulnerability, resilience, and the promise of personalised psychiatry. She also reflects on the role of science in society and how research can shape narratives around mental health, offering a thoughtful perspective on the future of the field.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

What does it mean to call something a “mental disorder”? Are biological explanations enough? In this episode, psychiatrist and philosopher of psychiatry Awais Aftab, USA, joins host Stefan Jerotic, Serbia, to unpack competing models of mental illness, the value of explanatory pluralism, how patient perspectives reshape psychiatric understanding and how conceptual clarity can make psychiatry more humane and scientifically grounded.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

This podcast with guest speaker Joaquim Radua, Spain, and host Michele De Prisco, Spain, is part of the Brains On Brains podcast series from ECNP. 
Is the future of psychiatry being shaped by data science? How can predictive models and neuroimaging support clinical care? What role will artificial intelligence play in transforming mental health research? 

In this episode, Michele De Prisco and Joaquim Radua discuss the intersection of psychiatry, neuroscience, and statistics, explore the promise and limits of AI, and reflect on the future of personalized mental health care. 

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

This podcast with speakers Tomas Hajek, Canada, Danella Hafeman, USA, Hanne Lie Kjærstad, Denmark, and host Luisa Klahn, Sweden, is part of the Congress Preview podcast series from ECNP.

Longitudinal studies help scientists understand why the course and outcomes of bipolar disorder vary so widely. In this episode, the speakers discuss brain changes, cognitive impairments, and mobile sensing, sharing insights from large, multi-modal cohort studies. They highlight how early markers and modifiable factors can guide prevention and treatment. Join them for their symposium at the 2025 ECNP congress in Amsterdam.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

This podcast with speakers Linda Simmler, Switzerland, Frederick Barret, United States, and host Friederike Holze, Switzerland, is part of the Congress Preview podcast series from ECNP.

They explore the therapeutic potential of psychedelics like psilocybin, discussing both preclinical and clinical research. Topics include synaptic plasticity, neural circuits, and the role of psychedelics in treating depression, anxiety, and addiction. The conversation highlights key challenges such as establishing causal links between neuroplasticity and therapeutic effects, predicting patient responses, and navigating public perception and funding. Join them for their symposium at the 2025 ECNP congress in Amsterdam.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

This podcast with guest speaker Alberto Giubilini, United Kingdom, and host Michele De Prisco, Spain, is part of the Brains On Brains podcast series from ECNP.
Can AI act as a moral advisor in psychiatry? What consent and equity dilemmas do we face? Should we fear or embrace these tools?

In this episode, Michele De Prisco and Alberto Giubilini explore AI ethics in mental health, share insights, and envision the future of AI-driven psychiatry.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

In this episode, Martin Picard, USA, from Columbia University, shares his academic journey into mitochondrial psychobiology and its groundbreaking links to mental health, with postdoctoral researcher and Early Career Academy member Jelena Brasanac, Germany. He discusses the role of mitochondria in stress, mental health, and mood, explaining how mitochondrial health could reshape approaches to treating mental health disorders. He also offers insights on leadership in academia and practical advice for early career scientists, making this conversation a valuable listen for anyone interested in the future of mental health science. 

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

In this Podcast episode, host Silvia Bruzzone, Denmark, is joined by Martien Kas, the Netherlands, and Hugh Marston, Germany, to discuss their recent publication in Molecular Psychiatry: “Precision Psychiatry Roadmap: Towards a Biology-Informed Framework for Mental Disorders.” 

Together, they examine the shortcomings of current diagnostic systems in psychiatry and present the vision behind the Precision Psychiatry Roadmap initiative led by ECNP. The conversation explores how combining biological, behavioural, and symptomatic data can revolutionise mental health care—paving the way for more personalised, effective treatments. 

You can find the full article here: https://www.nature.com/articles/s41380-025-03070-5

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

What is the role of neuroscience during today’s opioid epidemic? Join host Chiara Montemitro, Sweden, for an essential conversation with Siri Leknes, Norway, as she reflects on her diverse journey to a better understanding of pain and pleasure while addressing the staggering rise in opioid-related deaths. Discover the personal and professional insights that shaped Leknes’ career, including candid reflections on the challenges she faced and the complexities of academia.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Tune in to this captivating podcast episode featuring Prof. Brenda Penninx, the Netherlands, a renowned professor of psychiatric epidemiology. Brenda engages in a stimulating conversation with Marieke Klein, The Netherlands, sharing her scientific journey and groundbreaking research on depression. Discover how interdisciplinary research is paving the way for personalized mental health treatments. Brenda also offers a glimpse into her illustrious career and offers valuable advice to aspiring scientists. Don't miss this inspiring and informative discussion!

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.